AZD2716

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T30255-5mg	5 mg				7 - 10 business days*		632.00€
TGM-T30255-25mg	25 mg				7 - 10 business days*		1,982.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: AZD2716 is an effective selective phospholipase A2 inhibitor for the treatment of... more

Close menu

Product information "AZD2716"

Description: AZD2716 is an effective selective phospholipase A2 inhibitor for the treatment of coronary artery and cardiovascular disease. Target: Others. Smiles: C(N)(=O)C1=C(C=C(CC2=CC=CC=C2)C=C1)C3=CC(C[C@H](C(O)=O)C)=CC=C3. References: An Enantioselective Hydrogenation of an Alkenoic Acid as a Key Step in the Synthesis of AZD2716 Staffan Karlsson, Henrik Sörensen, Sören M. Andersen, Angele Cruz, and Per Ryberg Org. Process Res. Dev., Articles ASAP (As Soon As Publishable) Publication Date (Web): January 7, 2016 (Article) doi: 10.1021/acs.oprd.5b00382

Keywords:	AZD 2716, AZD-2716
Supplier:	TargetMol
Supplier-Nr:	T30255

Properties

Application:	SPLA2 inhibitor
MW:	373.44 D
Formula:	C24H23NO3

Database Information

CAS :	1845753-81-2\| Matching products
KEGG ID :	K01047 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "AZD2716"

Write a review